Gabrielle M. Gualtieri

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Gabrielle M. Gualtieri is an author at Pfizer (United States) specializing in drug discovery, cytochrome p450-mediated metabolism, and selectivity profiling.

Publications per year

2022–2024

Publications

Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach

Angela C. Doran, Woodrow Burchett, Connor Landers et al. · Drug Metabolism and Disposition · 2022 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans

Jonathan Bauman, Angela C. Doran, Gabrielle M. Gualtieri et al. · Drug Metabolism and Disposition · 2024 · 12 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

An Improved Method for Cytochrome P450 Reaction Phenotyping Using a Sequential Qualitative-Then-Quantitative Approach

Angela C. Doran, Alyssa Dantonio, Gabrielle M. Gualtieri et al. · Drug Metabolism and Disposition · 2022 · 11 citations · Full text

Medicine, Biochemistry, Pharmacology +12

1–3 of 3